191118-43863

CourtBoard of Veterans' Appeals
DecidedSeptember 30, 2021
Docket191118-43863
StatusUnpublished

This text of 191118-43863 (191118-43863) is published on Counsel Stack Legal Research, covering Board of Veterans' Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
191118-43863, (bva 2021).

Opinion

Citation Nr: AXXXXXXXX Decision Date: 09/30/21 Archive Date: 09/30/21

DOCKET NO. 191118-43863 DATE: September 30, 2021

ORDER

Entitlement to an initial rating of 30 percent, but no higher, for gastroesophageal reflux disease (GERD) is granted.

FINDING OF FACT

The Veteran's GERD is manifested by frequent episodes of epigastric distress with pyrosis, reflux, regurgitation, and substernal pain productive of considerable health impairment.

CONCLUSION OF LAW

Resolving reasonable doubt in the Veteran's favor, the criteria for an initial rating of 30 percent, but no higher, for service-connected GERD have been more nearly approximated. 38 U.S.C. § 1155; 38 C.F.R. § 4.114, Diagnostic Code 7399-7346.

REASONS AND BASES FOR FINDING AND CONCLUSION

The Veteran served on active duty from November 1998 to February 2005. He also served on active duty for training from August to December 1996. He was awarded the Combat Infantry Badge and the Purple Heart.

This matter comes before the Board of Veteran's Appeals (Board) on appeal from October 2019 rating decisions by a Department of Veterans Affairs Regional Office (RO) under the Appeals Modernization Act (AMA).

Within the framework of the AMA, the Veteran submitted a VA Form 10182, Decision Review Request: Board Appeal (Notice of Disagreement) and elected Direct Review by a Veterans Law Judge in November 2019. See November 2019 VA Form 10182 Notice of Disagreement. The Board notes that under the direct review option, no additional evidence received after the appealed rating decision is to be considered; rather, review is limited to the evidence on record at the time of the decision. 38 C.F.R. §§ 19.2(d), 20.301.

In July 2020, the Board denied the Veteran's increased rating claim for GERD. The Veteran appealed the Board decision to the United States Court of Appeals for Veterans Claims (Court). In May 2021, the Court granted the Joint Motion for Partial Remand filed by representatives for both parties, vacating the July 2020 Board's decision and remanding the claim to the Board for further proceedings consistent with the Joint Motion.

Entitlement to an initial rating in excess of 10 percent for GERD.

As an initial matter, the Veteran filed his claim for entitlement to service connection for GERD on December 10, 2018. See December 2018 VA 21-526EZ, Fully Developed Claim (Compensation). The RO granted the Veteran's claim in a May 2019 rating decision and assigned a 10 percent rating, effective December 10, 2018. See May 2019 Rating Decision Narrative.

The Veteran's GERD has been evaluated under DC 7399-7346. 38 C.F.R. § 4.114. The hyphenated diagnostic code used in this case indicates that a digestive disorder under DC 7399 is the service-connected disorder, and DC 7346 identifies the basis for the evaluation assigned. 38 C.F.R. § 4.27. Because there is no diagnostic code specifically for GERD, it is rated by analogy to hiatal hernia, under DC 7346.

Under DC 7346, a 10 percent rating is warranted for hiatal hernia with two or more of the symptoms listed in the criteria for a 30 percent rating, but of less severity. A 30 percent rating is assigned for persistently recurrent epigastric distress with dysphagia, pyrosis and regurgitation accompanied by substernal or arm or shoulder pain and productive of considerable impairment of health. Symptoms of pain, vomiting, material weight loss, and hematemesis or melena with moderate anemia or other symptom combinations productive of severe impairment of health equate to the highest rating of 60 percent. 38 C.F.R. § 4.114, DC 7346.

A November 2018 ambulatory care note shows that the Veteran reported four bloody loose stools. He also reported abdominal bloating and pain and nausea but denied melena and vomiting. The assessment included gastrointestinal bleed likely due to nonsteroidal anti-inflammatory drug (NSAID) induced gastropathy. See December 2018 CAPRI.

A December 2018 VA gastroenterology consultation shows that the Veteran reported that he had been feeling bloated and gaseous for approximately two months. He also endorsed occasional heartburn and epigastric pains in the lower right quadrant of his abdomen but denied nausea and vomiting. The assessment included symptoms of bloating with increased gas, GERD and epigastric pain, right lower quadrant abdominal pain, and history of rectal bleeding.

At a February 2019 VA examination for esophageal conditions, the examiner diagnosed the Veteran with GERD. The examiner noted that the Veteran's GERD was manifested by symptoms of reflux, substernal pain, sleep disturbance caused by esophageal reflux, nausea, and vomiting. The examiner noted that the Veteran did not have an esophageal stricture, spasm of the esophagus or acquired diverticulum of the esophagus and did not find any other pertinent physical findings, complications, signs, or symptoms related to GERD. The examiner further stated that the Veteran's esophageal disability impacted his ability to work by causing mild to moderate epigastric pain, burning, and intermittent nausea and vomiting.

The Veteran also underwent a VA examination for intestinal conditions in February 2019. The examiner diagnosed the Veteran with flatulence secondary to the medication he took as treatment for GERD. The examiner also noted signs and symptoms attributable to the Veteran's intestinal disability, to include abdominal bloating, gas, distention, and frequent episodes of bowel disturbance with abdominal distress. See February 2019 C&P examination.

In support of his claim, the Veteran submitted a private disability benefit questionnaire from Dr. A. Wright dated in August 2019. Dr. Wright noted that the Veteran had been diagnosed with GERD, for which he was required to take continuous medication. Dr. Wright noted that the Veteran's GERD was manifested by symptoms of persistent recurrent epigastric distress, dysphagia, pyrosis, reflux, regurgitation, substernal pain, and sleep disturbance, which occurred four or more times a year, with each episode lasting less than one day. She noted that the Veteran did not have an esophageal stricture, spasm of the esophagus or acquired diverticulum of the esophagus but noted other pertinent physical findings, complications, signs, or symptoms related to GERD, to include epigastric pain and abdominal bloating. Following her examination, Dr. Wright stated that the Veteran's GERD impacted his ability to work because he had to go to the washroom for fear of vomiting during episodes. See September 2019 VA examination.

The Veteran also underwent a VA examination for esophageal conditions in October 2019. The examiner noted that the Veteran's GERD symptoms manifested as pyrosis, reflux, and regurgitation and stated that he took continuous medication to control his symptoms. The examiner noted that the Veteran did not have an esophageal stricture, spasm of the esophagus or acquired diverticulum of the esophagus and did not have any other pertinent physical findings, complications, signs, or symptoms related to GERD. Following her examination, the examiner opined that the Veteran's GERD did not impact his ability to work. See October 2019 C&P examination.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Esteban v. Brown
6 Vet. App. 259 (Veterans Claims, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
191118-43863, Counsel Stack Legal Research, https://law.counselstack.com/opinion/191118-43863-bva-2021.